Big pharma: CVS sells major debt dose as bankers pin hopes on M&A
![CVS Pharmacy](https://assets.euromoneydigital.com/dims4/default/765645a/2147483647/strip/true/crop/230x150+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F37%2Ffb%2F4f9a9dbd90b553bbfd3f3590a61f%2Fcvs-pa-230x150.jpg)
CVS Health printed the third-biggest bond deal of all time as it funded its $67.5bn acquisition of Aetna. Bankers hope that a revival in M&A activity will provide a shot in the arm for supply.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: